Introduction Stargardt disease (STGD) is an autosomal recessive macular dystrophy with a prevalence of 1 in 6000 to 1 in 10 000, characterized by retinal atrophic lesions, also known as chorioretinal atrophy, involving loss of photoreceptors, retinal pigment epithelium (RPE), and underlying choriocapillaris.1-3 Retinal atrophic lesions cause profound visual disturbances and progressive vision loss, including declines in visual acuity, visual fields, and night vision, as well as chromatopsia,...
Husband, father of two, technophile, life hacker, academic urologist. Proud alumnus of @brady_urology, @umiamimedicine, & @umich. EIC of @BJUICompass.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Michael Gorin
ChatGPT Health performance in a structured test of triage recommendations
Abstract ChatGPT Health was launched in January 2026 as OpenAI’s consumer health tool and has reached millions of users. Here we conducted a structured stress test of triage recommendations using 60 clinician-authored vignettes across 21 clinical domains under 16 factorial conditions, yielding 960 total responses. Performance followed an inverted U-shaped pattern, with the most dangerous failures concentrated at clinical extremes—nonurgent presentations (35%) and emergency conditions (48%).
Rare genetic variation in PTPRB is associated with central serous chorioretinopathy, varicose veins and glaucoma - Nature Communications
Abstract Central serous chorioretinopathy is an eye disease characterized by fluid buildup under the central retina whose etiology is not well understood. Abnormal choroidal veins in central serous chorioretinopathy patients have been shown to have similarities with varicose veins. To identify potential mechanisms, we analyzed genotype data from 1,477 patients and 455,449 controls in FinnGen.
Case of the Month from the Icahn School of Medicine at Mount Sinai, New York, NY: MRI/TRUS fusion‐guided biopsy of a local prostate cancer recurrence using the bladder for image registration
Case of the Month Case of the Month from the Icahn School of Medicine at Mount Sinai, New York, NY: MRI/TRUS fusion-guided biopsy of a local prostate cancer recurrence using the bladder for image registration Patrick Ho, Patrick Ho The Milton and Carroll Petrie Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA Search for more papers by this authorBasil Kaufmann, Basil Kaufmann The Milton and Carroll Petrie Department of Urology, Icahn School of Medicine at...
Utility of PSMA PET/CT in Staging and Restaging of Renal Cell Carcinoma: A Systematic Review and Metaanalysis
DISCUSSION In this study, we systematically reviewed all the available literature on the utility of PSMA PET/CT imaging in staging or restaging of RCC (supplemental tables) and performed a metaanalysis on the eligible relevant studies when feasible. To our knowledge, this was the first metaanalysis assessing the detection rate of PSMA PET/CT in this patient population.
Cinematic rendering of 18F‐DCFPyL PET/CT fusion data in a patient with metastatic clear cell renal cell carcinoma
Three-dimensional visualizations of volumetric data are utilized for a variety of applications in medical imaging.1 Recently, a method known as cinematic rendering has been applied to standard acquisitions of medical image data to create photorealistic visualizations with high levels of surface detail.2, 3 The technique is based on complex path tracing that models the movement of millions of photons through a volume and includes information on how those photons interact with the matter in the...
Protocol for a MULTI-centre feasibility study to assess the use of 99mTc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study)
Methods and analysis Study methods are reported with reference to Standard Protocol Items: Recommendations for Interventional Trials Checklist (SPIRIT)19 and SPIRIT-Path extension for cellular and molecular pathology content in clinical trial protocols.20 Study design A prospective, multicentre study to assess the feasibility and diagnostic performance characteristics of 99mTC-sestamibi SPECT/CT in adults (n=50) with solid, enhancing clinical renal tumours (2–7 cm) on cross-sectional imaging.
Combating reviewer fatigue with carrots
I am excited to share the January 2023 issue of BJUI Compass with our readers. This issue of the Journal includes three review articles, two research letters, one editorial and eight original articles across a range of topics in urology. This is the largest issue we have published to date, and it is a testament to the hard work of our authors, reviewers and editorial team.
PSMA-targeted PET Imaging of Prostate Cancer - A Primer for Urologists - Michael Gorin
Read the Full Video Transcript Michael Gorin: PSMA-targeted PET Imaging of Prostate Cancer, a Primer for Urologists. So first let's start with reviewing conventional imaging modalities for prostate cancer. Well, the audience should already be very familiar with imaging options for primary prostate cancer, and this includes a multi-parametric MRI of the prostate.
Symposium Discussion on PSMA-Targeted PET Imaging and Interpretation - What Urologists Need to Know
Read the Full Video Transcript Linda Budzinski: Can you comment on your experience with PYLARIFY DCF PyL and how it impacts your management of men at staging? Does it potentially change your surgical approach? Second, do you think these PSMA scans will replace conventional imaging and staging? And third, in the BCR setting, what is your threshold for PSMA scanning if would you have one?
Outcomes of Freehand Transperineal Prostate Biopsy with Omission of Antibiotic Prophylaxis
ORIGINAL ARTICLE Shaan Setia, John Smith, Rush University College of Medicine, Chicago Search for more papers by this author Demetri Cendo, University of Maryland, College Park Search for more papers by this author Michael Gorin, Matthew Allaway, Srinivas Vourganti, Corresponding Author srinivas_vourganti@rush.edu Rush University Medical Center, Chicago Corresponding author Rush University Medical Center, 1725 W Harrison St, Suite 970, Chicago, IL 60612 Email: srinivas_vourganti@rush.edu...
Automakers trying to figure out what's causing fires in electric vehicles
It’s happened only in rare instances but some carmakers have been trying to figure out what’s causing their electric vehicles to catch fire — sometimes when the cars are getting their batteries recharged. The most dramatic example happened eight months ago in San Ramon, where a blaze erupted in the garage of the home owned by Jorgen and Carolyn Vindum, where their two Teslas were parked.
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate-Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY) | Journal of Urology
Open AccessJournal of UrologyAdult Urology Article26 Feb 2021 Abstract PURPOSE: PSMA-targeted PET/CT has the potential to improve the detection and localization of prostate cancer (PCa). OSPREY was a prospective trial designed to determine the diagnostic performance of 18F-DCFPyL-PET/CT for detecting sites of metastatic PCa. METHODS: Two patient populations underwent 18F-DCFPyL-PET/CT: Cohort A enrolled men with high-risk PCa undergoing radical prostatectomy with pelvic lymphadenectomy.
Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase 3, Multicenter Study
Research Article Michael J. Morris, Steven P. Rowe, Michael A. Gorin, Lawrence Saperstein, Frédéric Pouliot, David Y Josephson, Jeffrey YC Wong, Austin R Pantel, Steve Y Cho, Kenneth L Gage, Morand R Piert, Andrei Iagaru, Janet H. Pollard, Vivien Wong, Jessica Jensen, Tess Lin, Nancy Stambler, Peter Carroll and Barry A Siegel DOI: 10.1158/1078-0432.CCR-20-4573 Abstract PURPOSE: Current FDA-approved imaging modalities are inadequate for localizing prostate cancer biochemical recurrence (BCR).
Drones al rescate: como los drones están ayudando en la lucha contra el COVID-19
Avisos de "quédese en casa" vigentes en todo el mundo, una improbable tecnología ha venido a ayudar a las agencias de seguridad pública responsables por hacer cumplir las medidas: drones. Funcionarios gubernamentales en todos lados les han pedido a los ciudadanos que practiquen distanciamiento social y se queden en casa para aplanar la curva de la propagación del COVID-19.
When Genetics Can Point Researchers and Clinicians in New Directions
Ophthalmologists and clinicians throughout all disciplines of medicine and surgery have been deluged in recent years by the exponential growth of molecular genetic association studies (both of candidate genes and genome-wide) for a growing number of disorders, especially complex genetic conditions that defy traditional mendelian inheritance.
Editorial: Preoperative PSMA‐targeted PET imaging: more than just a tool for prostate cancer staging?
Rate this article: Editorial: Preoperative PSMA‐targeted PET imaging: more than just a tool for prostate cancer staging? 10 views The presence of lymph node metastases at the time of prostate cancer diagnosis has significant implications for treatment.
First point-of-care PSA test for prostate cancer detection
Affiliations The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA Alexa R. Meyer & Michael A. Gorin Authors Search for Alexa R. Meyer in: Search for Michael A. Gorin in: Competing interests The authors declare no competing interests. Corresponding author Correspondence to Michael A. Gorin.
Magnetic Resonance Imaging Prior to First Prostate Biopsy-Are we there yet?
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Traditionally, prostate cancer has been the only solid tumor diagnosed by random biopsies without identification of a specific target on imaging. Typically, 10 to 12 biopsy cores are obtained by following a systematic template.
PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA-targeted PET Imaging Studies
Beginning in 2012, [18F]- and [68Ga]-labeled inhibitors of prostate-specific membrane antigen (PSMA) entered early clinical development for positron emission tomography (PET) imaging of prostate cancer (PCa) and showed immediate promise for sensitive and specific identification of local and distant sites of disease [[1], [2]].
Kidney cancer: PSMA: a potential therapeutic target in RCC
Prostate-specific membrane antigen (PSMA) is expressed by prostate cancer cells as well as endothelial cells within the neovasculature of a number of malignancies including renal cell carcinoma (RCC). PET radiotracers that target PSMA have shown great promise for imaging RCC. Agents that target PSMA also have the potential to be used as therapeutics in patients with this malignancy.
Editorial: Defining the clinical utility of PSMA-targeted PET imaging of prostate cancer
In the field of oncology, positron emission tomography (PET) is most commonly performed using 2-deoxy-2-[18F]fluoro-d-glucose (18F-FDG), a radiofluorinated glucose analogue that accumulates in cells undergoing aerobic glycolysis. Unfortunately, because of the low glycolytic activity of hormone-naïve prostate cancer cells, 18F-FDG PET has been of little value in imaging men with this malignancy [1].
The Landscape of Whole-genome Alterations and Pathologic Features in Genitourinary Malignancies: An Analysis of the Cancer Genome Atlas
The accumulation of somatic genetic alterations drives carcinogenesis. Little is known, however, about how the level of genetic alteration across an entire cancer genome affects tumor grade, stage or survival. To investigate the influence of somatic mutation count (MC) and copy number variation (CNV) on pathologic and oncologic outcomes in patients with genitourinary malignancies in The Cancer Genome Atlas (TCGA).
Mortality trends and the impact of lymphadenectomy on survival for renal cell carcinoma patients with distant metastasis
NEW FEATURE! CUAJ is now providing readers an opportunity to obtain continuing professional development Section 3 credits of the Maintenance of Certification (self-assessment) program with the Royal College of Physicians and Surgeons of Canada. Simply read the accredited article and answer the short multiple choice questionnaire. Then, enter your email address to receive a certificate of participation from CUA.
PSMA-Targeted 18F-DCFPyL PET/CT Imaging of Clear Cell Renal Cell Carcinoma: Results from a Rapid Autopsy
a The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA b The Russell H.
Editorial: PSMA-targeted imaging of PCa - the best is yet to come
In recent years there has been increasing interest in imaging recurrent or metastatic prostate cancer with positron-emission tomography (PET) radiotracers targeting prostate-specific membrane antigen (PSMA [1]). The majority of this work has been performed using urea-based small molecules labelled with gallium-68 (68Ga). Within this class of radiotracers, 68Ga-PSMA-11 (also known as 68Ga-PSMA-HBED-CC) has been the most widely studied. In this month’s edition of BJUI, van Leeuwen et al.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Michael
Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack